Surrozen attracts $33 mln Series A
South San Francisco-based Surrozen Inc, a newly formed biopharmaceutical company, has raised $33 million in Series A financing. The Column Group led the round.
15 February 2017•1 min read
South San Francisco-based Surrozen Inc, a newly formed biopharmaceutical company, has raised $33 million in Series A financing. The Column Group led the round.
